Krebs Biochemicals & Industries Limited

524518

INE268B01013

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 06:00:56 2024-06-21 EDT			5-day change	1st Jan Change
71.13 ^INR	-2.02%		-1.85%	-9.20%

05-21	Krebs Biochemicals & Industries Limited Appoints Rakesh Kalbate as Company Secretary/Compliance Officer	CI
05-21	Krebs Biochemicals & Industries Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	CI

Krebs Biochemicals & Industries Ltd. Appoints R. Ch. Satyanarayana as Independent Director

August 13, 2014 at 09:42 am

Krebs Biochemicals & Industries Ltd. announced that the Board of Directors of the Company at its meeting held on August 13, 2014, appointed Mr. R. Ch. Satyanarayana as Independent Director on the Board.

Latest news about Krebs Biochemicals & Industries Limited

Krebs Biochemicals & Industries Limited Appoints Rakesh Kalbate as Company Secretary/Compliance Officer	05-21	CI
Krebs Biochemicals & Industries Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	05-21	CI
Krebs Biochemicals & Industries Limited Announces Resignation of Keyur Doshi as Company Secretary, Compliance Officer	04-15	CI
Krebs Biochemicals & Industries Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-12	CI
Krebs Biochemicals & Industries Limited Appoints Keyur Doshi as Company Secretary, Compliance Officer	01-17	CI
Andhra Pradesh Pollution Control Board Orders Production Halt at Krebs Biochemicals Plant	12-18	MT
Krebs Biochemicals & Industries Limited Announces Resignation of Rohit Taparia as Company Secretary and Compliance Officer	23-10-20	CI
Krebs Biochemicals & Industries Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-09	CI
Krebs Biochemicals & Industries Limited Approves Resignation of Mr. Pabitrakumar Kalipada Bhattacharya as Managing Director	23-08-09	CI
Krebs Biochemicals Limited Announces Executive Changes, Effective 10 August 2023	23-08-09	CI
Krebs Biochemicals Trims Net Loss in Fiscal Q4	23-05-24	MT
Krebs Biochemicals & Industries Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	23-05-24	CI
Krebs Biochemicals Names New CFO	23-02-03	MT
Krebs Biochemicals & Industries Limited Approves Appointment of Rohit Taparia as Company Secretary and Compliance Officer	23-02-03	CI
Krebs Biochemicals & Industries Limited Approves CFO Changes	23-02-03	CI
Krebs Biochemicals & Industries Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-11-10	CI
Krebs Biochemicals & Industries Limited Auditor Raises 'Going Concern' Doubt	22-09-05	CI
Krebs Biochemicals & Industries Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	22-08-01	CI
Taruni Banda Resigns as Company Secretary and Compliance Officer of Krebs Biochemicals & Industries Limited, Effective from August 6, 2022	22-08-01	CI
Krebs Biochemicals & Industries Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022	22-05-23	CI
Krebs Biochemicals & Industries Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	22-02-12	CI
Krebs Biochemicals & Industries Limited announced that it has received INR 1 billion in funding from Ipca Laboratories Limited	21-12-29	CI
Krebs Biochemicals & Industries Limited Appoints Jitendra Shah as Additional Director, Non-Executive Category	21-11-09	CI
Krebs Biochemicals & Industries Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	21-11-09	CI
Krebs Biochemicals & Industries Limited to Consider Resignation of E J Babu as Non-Executive Director	21-11-02	CI

Chart Krebs Biochemicals & Industries Limited

Duration

Period

Chart Krebs Biochemicals & Industries Limited

More charts

Company Profile

Krebs Biochemicals & Industries Ltd is an India-based company, which is engaged in the business of manufacture of active pharmaceutical ingredients. The Company manufactures bulk active pharmaceutical ingredients, pharmaceutical intermediates, fine chemicals, nutraceuticals utilizing two revenue streams: contract manufacturing for large pharmaceutical and multinational companies, and development of its products for sale in global markets. Its products include Androstenedione, Lovastatin, and Simvastatin. The Companyâs pilot or research and development stages products are Amlodipine, Cetirizine, Orlistat, Serratiopepetidase, Telmisartan, and Phenylephrine. The Company has two manufacturing facilities one at Regadichelaka, Nellore District and another one at Kothapalli Village, Kasimkota Mandal, Visakhapatnam District, Andhra Pradesh, India.

Sector

Pharmaceuticals

Calendar

2024-08-08 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
KREBS BIOCHEMICALS & INDUSTRIES LIMITED	-9.20%	18.71M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+16.50%	42.2B
OTSUKA HOLDINGS CO., LTD.	+20.78%	21.24B
SANDOZ GROUP AG	+21.14%	15.89B
CIPLA LIMITED	+23.69%	14.91B
ZYDUS LIFESCIENCES LIMITED	+57.44%	13.1B
THE MEDICINES COMPANY	-0.05%	6.79B
ONO PHARMACEUTICAL CO., LTD.	-14.94%	6.24B
ASPEN PHARMACARE HOLDINGS LIMITED	+20.03%	6.08B
STADA ARZNEIMITTEL	-8.87%	5.73B